Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Abnormality, Heart

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Abnormality, Heart in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Wakeel-Marquard, N; Berger, F; Kuehne, T; Messroghli, DR; Muench, F; O H-Ici, D; Rastin, S; Yilmaz, S1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Abnormality, Heart

ArticleYear
Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.
    The international journal of cardiovascular imaging, 2017, Volume: 33, Issue:12

    Topics: Adolescent; Adult; Case-Control Studies; Contrast Media; Female; Fibrosis; Heart Defects, Congenital; Heart Ventricles; Heterocyclic Compounds; Humans; Infusions, Parenteral; Injections; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Young Adult

2017